1 American Psychiatric Association.
Diagnostic and Statistic Manual of Mental Disorders.
Fourth Edition, Dsm-IV, Washington D.C. 1994.

2 Miller BL.
Clinical advances in degenerative dementia.
Br J Psych 1997;171:1-3.

3 Brayne C, Gill C, Huppert FA, Barkley C, Gehlhaar E, Girling DM, et al.
Incidence of clinically diagnosed subtypes of dementia in an elderly population.
Br J Psych 1995;167:255-62.

4 Loeb C.
Le demenze.
In: Fazio C, Loeb C, eds. Neurologia. Roma: Società Editrice Universo 1996:826-41.

5 Roses AD.
A model for susceptibility polimorphysm for complex diseases: Apolipoprotein E and Alzheimer's disease.
Neurogenetics 1997;1:3.

6 Goate A, Chartier-Harlin MC, Mullan M.
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.
Nature 1991;349:704-7.

7 Schellemberg GD.
Genetic dissection of Alzheimer's disease: a heterogeneous disorder.
Proceedings of the National Academy of Sciences of the United States of America 1995;92:8552-9.

8 Rogaev E, Sherrington R, Liang Y.
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to Alzheimer's disease type 3 gene.
Nature 1995;376:600-2.

9 Roses AD.
Apolipoprotein E affects the rate of Alzheimer's disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease.
J Neuropathol Exp Neurol 1994;53:429-37.

10 Selkoe DJ.
Alzheimer's Disease: Genotype, Phenotype, and Treatments.
Science 1997;275:630-1.

11 Lipton SA.
HIV displays his coat of arms.
Nature 1994;367:113-4.

12 Brun A.
Frontal lobe degeneration of non-Alzheimer type 1: Neuropathology.
Arch Gerontol Geriatr 1987;6:193-208.

13 Neary D, Snowden JS, Northen B, Goulding P.
Dementia of frontal lobe type.
J Neurol Neurosurg Psychiatry 1988;51:353-61.

14 Gustafson L.
Frontal lobe degeneration of non-Alzheimer type II: Clinical picture and differential diagnosis.
Arch Gerontol Geriatr 1987;6:209-23.

15 Read S, Miller BL, Mena I.
SPECT in dementia: Clinical and pathological correlation.
J Am Geriatr Soc 1995;43:1243-7.

16 Sparks DL, Markersbery WR.
Altered serotonergic and cholinergic synaptic markers in Pick's disease.
Arch Neurol 1991;48:769-99.

17 Miller BL, Darby A, Benson DF, Cummings JL, Miller MH.
Aggressive, socially disruptive and antisocial behaviour associated with fronto-temporal dementia.
Br J Psychiatry 1997;170:150-5.

18 McKeith IG, Galasko D, Kosaka K, et al.
Clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the CDLB international workshop.
Neurology 1996;47:1113-25.

19 Hansen L, Salmon D, Galasko D.
The Lewy body variant of Alzheimer's disease: A clinical and pathological entity.
Neurology 1990;40:1-8.

20 Perry EK, Marshall E, Kerwin J, et al.
Evidence of monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia.
J Neurochem 1990a;55:1454-6.

21 Perry RH, Irving D, Blessed G, et al.
Senile dementia of Lewy body type.
J Neurol Sci 1990b;95:119-39.

22 McKeith IG, Galasko D, Wilcock G, Bryne JE.
Lewy Body Dementia-Diagnosis and Treatment.
Br J Psychiatry 1995;167:709-17.

23 Schmand B, Jonker C, Geerlings MI, Lindeboom J.
Subjective memory complaints in the elderly: depressive symptoms and future dementia.
Br J Psychiatry 1997;171:373-6.

24 Rosen J, Colantonio A, Becker TJ, Lopez OL, DeKosky ST, Moss HB.
Effects of a History of Heavy Alcohol Consumption on Alzheimer's Disease.
Br J Psychiatry 1993;163:358-63.

25 Burns A, Jakoby R, Levy R.
Psychiatric phenomena in Alzheimer's disease.
Br J Psychiatry 1990a;114:797-811.

26 Burns A, Luthert P, Levy R, Jakoby R.
Accuracy of clinical diagnosis of Alzheimer's disease.
Br Med J 1990b;301:1026.

27 Stern Y, Albert M, Brandt J, Jacobs DM, Tang MX, Marder K.
Utility of extrapyramidal signs and psychosis as predictors of cognitive and functioning decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study.
Neurology 1994;44:2300-7.

28 Forstl H, Burns A, Levy R, Cairns N, Luthert P, Lantos P.
Neuropathological Correlates of Behavioural Disturbance in Confirmed Alzheimer's Disease.
Br J Psychiatry 1993;163:364-8.

29 Gottfries CG, Blennow K, Wallin A.
Clinical Diagnostic Criteria in Dementia.
In: Gottfries CG, Levy R, Clincke G, Tritsmans L, eds. Diagnostic and Therapeutic Assessments in Alzheimer's Disease. Wrightson Biomedical Publishing Ltd 1991.

30 Klatka LA, Louis ED, Schiffer RB.
A clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups.
Neurology 1996;47:1148-52.

31 McKeith IG, Perry RH, Fairban AF.
Operational criteria for senile dementia of the Lewy body type (SDTL).
Psychol Med 1992;22:911-22.

32 Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A.
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging.
Neurology 1997;48:1517-21.

33 Honjo H, Tamura T, Matsumoto Y.
Estrogen as a growth factor to central nervous cells. Estrogen treatment promotes development of acetylcholinesterase-positive basal forebrain neurons transplanted in the anterior eye chamber.
J Steroid Biochem Mol Biol 1992;41:633-5.

34 Asthana S, Craft S, Baker L.
Transdermal estrogen replacement therapy improves memory in women with Alzheimer's disease.
(Abstract) Soc Neurology 1996;22:200.

35 Stewart WF, Kawas C, Corrada M, Metter J.
Risk of Alzheimer's disease and duration of NSAID use.
Neurology 1997;48:626-32.

36 Small WG, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SM.
Diagnosis and treatment of Alzheimer's disease and related disorders. Consensus statement of the American Association for Geriatric Psichiatry, the Alzheimer's Association and the American Geriatrics Society.
J Am Med Assoc 1997;278:1363-71.

37 Herrman N, Rivard MF, Ward C.
Risperidone for the treatment of behavioral disturbances in Dementia: a case series.
J Neuropsychiatry Clin Neurosci 1998;10:220-3.

38 Burke WJ, Pfeiffer RF, McComb RD.
Neuroleptic Sensitivity to Clozapine in Dementia with Lewy Bodies.
J Neuropsychiatry Clin Neurosci 1998;10:227-9.

39 Casacchia M, Pollice R, Matteucci M, Roncone R.
Brain serotonin and the mechanism of action of selective serotonin re-uptake inhibitors (SSRI).
Arch Gerontol Geriatr 1998;(suppl.)6:65-70.

40 Morris RG, Morris LW, Britton PG.
Factors affecting the emotional wellbeing of the caregivers of dementia suffers.
Br J Psychiatry 1988;153:147-56.

41 Morris RG, Woods RT, Britton PG, Morris LW.
Gender differences in carers of dementia suffers.
Br J Psychiatry 1991;158:69-74.

42 Philp I, McKee KJ.
Community care for demented and non-demented elderly people: a comparison study of financial burden, service use, and unmet needs in family supporters.
Br Med J 1995;310:1503-6.

43 Livingstone G, Manela M, Katona C.
Cost of community care for older people.
Br J Psychiatry 1997;171:56-9.

44 Kahan J, Kemp B.
Decreasing the burden in families caring for a relative with dementing illness: a controlled study.
J Am Geriatr Ass 1985;33:664-70.

45 Glosser G, Wexler D.
Participants' evaluation of educational/support groups for families of patients with Alzheimer's disease and other dementia.
Gerontologist 1985;25:232-6.

46 Zarit SH, Orr NK, Zarit JM.
Interventions for families of dementia patients: a stress-management model.
In: Zarit SH, Orr NK, Zarit JM, eds. The hidden victims of Alzheimer's disease: families under stress. New York: New York University Press 1985:87-112.

47 Teri L, Logsdon RG, Uomoto J, McCurry SM.
Behavioral treatment of depression in patients with dementia.
Alzheimer's disease Association Disorders 1994;8(suppl 3):66-74.

48 Teri L, Logsdon RG, Uomoto J, McCurry SM.
Behavioral treatment of depression in dementia patients: a controlled clinical trial.
J Geriatr (B) 1997;52:159-66.

49 Knight B, Lutzky S, Macofsky-Urban F.
A meta-analytic review of interventions for caregiver distress: recommendations for future research.
Gerontologist 1993;33:240-8.

50 Mohide EA, Pringle DM, Streiner DL.
A randomized trial of family caregiver support in the home management of dementia.
J Am Geriatr Soc 1990;38:446-54.

51 Hebert R, Leclerc G, Bravo G.
Efficacy of a support group programme for caregivers of demented patients in the community: a randomized control trial.
Arch Gerontol Geriatr 1994;18:1-14.

52 Mittelman MS, Ferris SH, Shulman E, Levin B
A comprehensive support program: effect on depression in spouse - caregivers of AD patients.
Gerontologist 1995;35:17-30.

53 Witlatch CJ, Zarit SH, Goodwin PE, von Eye A.
Influence of the success of psychoeducational interventions on the course of family care.
Clin Gerontol 1995;16:17-30.

54 Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B.
A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial.
J Am Med Ass 1996;276:1725-31.

55 Lawton MP.
Respite for caregivers of Alzheimer's patients: research and practice.
New York: Springer-Verlag 1991.

56 Flint AJ.
Effects of respite care on patients with dementia and their caregivers.
Intern Psychogeriatr 1995;7:505-17.

57 Lawton MP, Brody EM, Saperstein AR
A controlled study of respite service for caregivers of Alzheimer's patients.
Gerontologist 1989;29:8-16.

58 Dunkin JJ, Anderson-Hanley C.
Dementia caregiver burden: a review of the literature and guidelines for assessment and intervention.
Neurology 1998;51(suppl.1):S53-60; discussion S65-7.Review.